Tue Aug 9, 2022 by OPLawSocialMedia on News
Investors in pharma stocks prepare themselves for billions in litigation charges related to heartburn drugs. Overview Investors are worried about potential U.S. litigation charges related to popular heartburn drug Zantac this week, so shares of GSK, Sanofi and Haleon fell sharply. The issue has been simmering for years, but investor concern exploded this week as the first legal action was […]